NK CELL COMPOSITION AND PREPARATIONS FOR IMMUNOTHERAPY AND METHODS FOR THEIR PRODUCTION Application EP-4004193-A4 European Patent Office 20 Mar 2024
Methods of treating a wound using epigenetic regulation Grant US-11814623-B2 United States of America 14 Nov 2023
FEEDER FREE CELL CULTURE METHODS FOR EXPANDING NATURAL KILLER CELL PREPARATIONS Application WO-2023089561-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
POLYMER-INTERACTION MOLECULE CONJUGATES AND METHODS OF USE Application WO-2023079524-A2 World Intellectual Property Organisation (WIPO) 11 May 2023
Method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor… Application US-20220333078-A1 United States of America 20 Oct 2022
Targeting microRNA-101-3p in cancer therapy Grant US-11459568-B2 United States of America 04 Oct 2022
Expansion of natural killer cells and ILC3 cells with novel aromatic compounds Application CN-113454207-A China 28 Sep 2021
METHOD FOR OBTAINING CAR-NK CELLS Application WO-2021107779-A1 World Intellectual Property Organisation (WIPO) 03 Jun 2021
LOW DENSITY CELL CULTURE Application WO-2021015615-A1 World Intellectual Property Organisation (WIPO) 28 Jan 2021
POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS Application WO-2020252464-A1 World Intellectual Property Organisation (WIPO) 17 Dec 2020
COMPOSITIONS AND METHODS FOR EXPANDING EX VIVO NATURAL KILLER CELLS AND THERAPEUTIC USES… Application EP-3634437-A4 European Patent Office 18 Nov 2020
NATURAL KILLER CELLS AND USES THEREOF Application US-20200330516-A1 United States of America 22 Oct 2020
EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS Application WO-2020113182-A1 World Intellectual Property Organisation (WIPO) 04 Jun 2020
IMPROVED METHOD FOR EX VIVO EXPANSION CD34+HSPCs INTO NK CELLS USING AN ARYL HYDROCARBON… Application WO-2017046142-A1 World Intellectual Property Organisation (WIPO) 23 Mar 2017
Tumor suppression using human placental perfusate and human placenta-derived intermediate… Grant US-9216200-B2 United States of America 22 Dec 2015
EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS Application WO-2013119118-A1 World Intellectual Property Organisation (WIPO) 15 Aug 2013
GENERATION OF NK CELLS AND NK-CELL PROGENITORS Application WO-2012128622-A1 World Intellectual Property Organisation (WIPO) 27 Sep 2012